Pentwater Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Pentwater Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-702,892	Closed	-$29M	–	185
2015 Q2	$29M	Buy	+702,892	New	+$25.2M	0.15%	62

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Pentwater Capital Management's BRLI Position: Q3 2015 in Review

Pentwater Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 702,892 shares — an estimated $29M sold.

Pentwater Capital Management first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $29M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Pentwater Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Pentwater Capital Management sold 702,892 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $29M.
Pentwater Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
Pentwater Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $29M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Pentwater Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.